Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
PVLA
$151.82
+1.23%
PVLA
· Palvella Therapeutics, Inc.
Market Cap
$2.16B
Shares
14.41M
All earnings calls
Earnings call · FY2025 Q2
Palvella Therapeutics, Inc. (PVLA) Q2 2025 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$0.86
Net income
-$9.47M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 14, 2025.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Projected cash at year end
year end 2025
|
$55M | — |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 14, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 14, 2025 · complete as-filed document